Firm Management
Johnson & Johnson to buy private drug developer for $1.75 billion
Johnson & Johnson (JNJ.N) agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.
EBay follows Icahn's advice, plans PayPal spinoff in 2015
EBay Inc's agreement on Tuesday to spin off PayPal next year will give the unit more flexibility to strike deals in the rapidly evolving payments space as growth at the company's traditional e-commerce business slows.
Chinese e-cigarette maker Kimree files for U.S. IPO
Chinese e-cigarette maker Kimree Inc filed to list its shares in the United States at a time when e-cigarette companies are finding it harder to raise capital amid rising competition and increasing regulatory oversight.
Lawson to buy supermarket chain Seijo Ishii for $500 million
Japanese convenience store operator Lawson Inc said on Tuesday that it would buy upscale supermarket chain Seijo Ishii Co for about 55 billion yen ($503 million), including debt, from investment fund Marunouchi Capital.